Li, Hongmei
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. [electronic resource]
- Journal of neuroimmunology Jan 2013
- 28-38 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
ISSN: 1872-8421
Standard No.: 10.1016/j.jneuroim.2012.08.013 doi
Subjects--Topical Terms: Adoptive Transfer--methods Animals Anti-Inflammatory Agents, Non-Steroidal--therapeutic use Antigens, CD--metabolism Butadienes--pharmacology CD4-Positive T-Lymphocytes--drug effects Cell Differentiation--drug effects Cell Line, Transformed Chronic Disease Coculture Techniques Cytokines--metabolism Dose-Response Relationship, Drug Encephalomyelitis, Autoimmune, Experimental--drug therapy Enzyme Inhibitors--pharmacology Female Flow Cytometry Gene Expression--immunology Interferon-alpha--pharmacology Lipopolysaccharides--pharmacology Macrophages--drug effects Mice Mice, Inbred Strains Mice, Transgenic Microglia--drug effects Myelin Proteolipid Protein--immunology Myelin-Oligodendrocyte Glycoprotein--immunology Nitriles--pharmacology Peptide Fragments--immunology Receptors, Antigen, T-Cell--genetics Secondary Prevention Severity of Illness Index T-Lymphocytes, Regulatory--drug effects Time Factors Tritium Zymosan--therapeutic use